{
    "clinical_study": {
        "@rank": "94002", 
        "arm_group": {
            "arm_group_label": "human apotransferrin", 
            "arm_group_type": "Experimental", 
            "description": "intravenous apotransferrin every 4-8 weeks"
        }, 
        "brief_summary": {
            "textblock": "Atransferrinemia is a very rare disorder, which is caused by a deficiency of the protein\n      transferrin. No regular treatment is available for these patients. The objective of this\n      study is to investigate the pharmacokinetics, efficacy and safety of Apotransferrin\n      replacement therapy in atransferrinemia patients."
        }, 
        "brief_title": "Apotransferrin in Atransferrinemia", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Congenital Atransferrinemia", 
        "condition_browse": {
            "mesh_term": "Metal Metabolism, Inborn Errors"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Established diagnosis of atransferrinemia, defined as serum levels of transferrin\n             below 40 mg/dl\n\n          -  Informed consent\n\n        Exclusion Criteria:\n\n          -  Known with allergic reactions against human plasma or plasma products\n\n          -  Having detectable anti-immunoglobulin A antibodies"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01797055", 
            "org_study_id": "MD2009.04"
        }, 
        "intervention": {
            "arm_group_label": "human apotransferrin", 
            "description": "intravenous infusion", 
            "intervention_name": "Human apotransferrin", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "transferrin", 
            "anemia", 
            "iron overload"
        ], 
        "lastchanged_date": "October 31, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "K Moser, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Aschaffenburg", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum Aschaffenburg"
                }, 
                "investigator": {
                    "last_name": "K Moser, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Andrea Biondi, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Monza", 
                        "country": "Italy", 
                        "zip": "20900"
                    }, 
                    "name": "AO San Gerardo"
                }, 
                "investigator": {
                    "last_name": "Andrea Biondi, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "C R Diaz de Heredia Rubio, PhD, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Vall d'Hebron Hospital"
                }, 
                "investigator": {
                    "last_name": "C R Diaz de Heredia Rubio, PhD, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Italy", 
                "Spain"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Dose Escalating Study to Evaluate Pharmacokinetics, Efficacy and Safety of Apotransferrin in Atransferrinemia Patients", 
        "other_outcome": [
            {
                "measure": "transferrin levels", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "adverse drug reactions", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }
        ], 
        "overall_contact": {
            "email": "i.kleinebudde@sanquin.nl", 
            "last_name": "Ilona Kleine Budde, PhD"
        }, 
        "overall_contact_backup": {
            "email": "p.strengers@sanquin.nl", 
            "last_name": "Paul Strengers, MD"
        }, 
        "overall_official": [
            {
                "affiliation": "Vall d'Hebron, Spain", 
                "last_name": "C R Diaz de Heredia Rubio, PhD, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "klinikum Aschaffenburg, Germany", 
                "last_name": "K Moser, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "AO San Gerardo Monza, Italy", 
                "last_name": "Andrea Biondi, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Germany: Paul-Ehrlich-Institut", 
                "Italy: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Hemoglobulin", 
                "safety_issue": "No", 
                "time_frame": "2 year"
            }, 
            {
                "description": "serum transferrin levels measured on several time points before and after infusion", 
                "measure": "pharmacokinetics", 
                "safety_issue": "No", 
                "time_frame": "first infusion"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01797055"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "iron overload in organs", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Sanquin", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanquin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}